Approaches in Hepatitis Vaccine Design and Vaccination Strategy
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Hepatitis Virus Vaccines".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 15
Special Issue Editor
Special Issue Information
Dear Colleagues,
Hepatitis B virus (HBV) causes both acute and chronic liver diseases. Chronic HBV infection can lead to severe complications, such as chronic hepatitis, liver failure, and hepatocellular carcinoma. A vaccine for HBV has been available since 1980, despite new infections and HBV-related complications and mortality increasing, particularly in resource-limited countries. Even with the availability of various antiviral drugs to treat chronic hepatitis, these treatments have not proven to be consistently effective over time. Additionally, recent studies suggest that HBV vaccines may offer therapeutic benefits; therefore, there is a need for new strategies to develop more effective treatments and vaccines to control HBV infection.
Therapeutic vaccines, particularly hepatitis B, are in development. They are designed to treat chronic infections by stimulating the body's immune system to clear the virus. While no therapeutic vaccine has yet achieved a functional cure, these vaccines are designed differently from preventative ones, often combining multiple viral antigens and sometimes using novel platforms like mRNA to induce a more potent and specific immune response capable of controlling. There is a need for further development of therapeutic vaccines concerning their composition, antigens, dosages, and methods of administration. This Special Issue will focus on addressing vaccine-related issues to achieve the overarching goal of the "Elimination of Hepatitis" in the near future.
We look forward to receiving your contributions.
Dr. Sheikh Mohammad Fazle Akbar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatitis B virus
- preventive vaccine
- therapeutic vaccine
- nature of vaccines
- route of administration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
